Pierre Vandepapelière is a Chief Executive Officer, Chief Medical Officer and Founder at Amyl Therapeutics. Pierre Vandepapelière attended Université catholique de Louvain.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Amyl Therapeutics | Chief Executive Officer, Chief Medical Officer and Founder | — | — | Detail |
Amyl Therapeutics | Board Member | — | — | Detail |